Study Objective: The objective of the current study is to evaluate the clinical efficacy and safety of Sensum+ treatment for patients with reduced penile sensitivity (RPS).

Synopsis of First Post Marketing Study

Synopsis of First Post Marketing Study

Sensum+ clinical studies

The information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made by a healthcare provider considering the unique characteristics of the patient.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This product is not intended for those with a medical condition. Use only as directed. Consult your physician before beginning any prescription drug. Consult your pediatrician before giving any products to children under 18 years of age. Free shipping offer is to the United States only.

*The testimonials and product reviews presented on this website are for education purposes only. The product reviews and statements were not solicited or paid for by the company.

The information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made by a healthcare provider considering the unique characteristics of the patient.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This product is not intended for those with a medical condition. Use only as directed. Consult your physician before beginning any prescription drug. Consult your pediatrician before giving any products to children under 18 years of age. Free shipping offer is to the United States only.

*The testimonials and product reviews presented on this website are for education purposes only. The product reviews and statements were not solicited or paid for by the company.

The information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made by a healthcare provider considering the unique characteristics of the patient.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This product is not intended for those with a medical condition. Use only as directed. Consult your physician before beginning any prescription drug. Consult your pediatrician before giving any products to children under 18 years of age. Free shipping offer is to the United States only.

*The testimonials and product reviews presented on this website are for education purposes only. The product reviews and statements were not solicited or paid for by the company.

Goldex

Study Design: Patients were selected based on an online survey (Questions 1-8, Appendix 1). Patients who fulfilled the age (18-year and older) and symptoms of reduced penile sensitivity criteria were selected for enrollment. After the screening preparation, which included the collection and evaluation of the patients sexual function information, Sensum+ was shipped by mail to each patient with instructions on how to apply the product and complete the surveys (Appendix 1 & 2). Patients were instructed to apply Sensum+ twice daily for the first two weeks (12 hour interval) followed by once daily for the remaining eight weeks. At the end of treatment period, patients were asked to complete the efficacy questions (9 & 10, Appendix 1) and safety survey (Appendix 2). Efficacy data are presented in percent patients who achieved improvement for penile sensitivity and who answered yes to improvement of ejaculatory time. The safety of the study product was based on reported adverse events (Appendix 2).

Search

© 2017 All Rights Reserved | Privacy Policy | Terms | Safety of Sensum+ | Contact | Email : SensumplusCustomerService@innovuspharma.com

Clinical Result: In this study, a total of 368 patients who met the age ( 18-year old male) and symptoms of reduced penile sensitivity criteria were enrolled in this study. Clinical efficacy evaluation and safety analysis were performed for all patients who used the product. Survey data analyses indicate that 80% (296) of the men surveyed reported an increase in sensitivity after application of Sensum+ and 77.4% (285) of men reported faster ejaculation time. There were no adverse events reported by the users or their partners.

Study Result: The results from the online survey study indicate that 10-week treatment with Sensum+ improved penile sensitivity and decreased ejaculatory time. The application of Sensum+ for patients with reduced penile sensitivity was safe and effective.

The information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made by a healthcare provider considering the unique characteristics of the patient.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This product is not intended for those with a medical condition. Use only as directed. Consult your physician before beginning any prescription drug. Consult your pediatrician before giving any products to children under 18 years of age. Free shipping offer is to the United States only.

*The testimonials and product reviews presented on this website are for education purposes only. The product reviews and statements were not solicited or paid for by the company.